Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder
Condition(s):Stroke; PFO – Patent Foramen Ovale; Cryptogenic Stroke; TIALast Updated:July 12, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Stroke; PFO – Patent Foramen Ovale; Cryptogenic Stroke; TIALast Updated:July 12, 2023Recruiting
Condition(s):Infection, Human Immunodeficiency Virus ILast Updated:June 19, 2018Completed
Condition(s):Neoplasms, RectalLast Updated:February 23, 2023Completed
Condition(s):AcromegalyLast Updated:September 21, 2023Recruiting
Condition(s):Weight LossLast Updated:November 26, 2018Unknown status
Condition(s):Product Surveillance, PostmarketingLast Updated:June 10, 2021Completed
Condition(s):Prostate CancerLast Updated:August 18, 2022Withdrawn
Condition(s):Differentiated Thyroid Carcinoma (DTC)Last Updated:October 7, 2021Completed
Condition(s):Cardiovascular Surgical ProcedureLast Updated:September 17, 2018Completed
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:July 10, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.